QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Curtis, A. L. Articles by Valentino, R. J. Search for Related Content PubMed PubMed Citation Articles by Curtis, A. L. Articles by Valentino, R. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Low Blood Pressure Hazardous Substances DB NALOXONE VASOPRESSIN

Next Article 

The Journal of Neuroscience, 2001, 21:RC152:1-5

RAPID COMMUNICATION
Evidence for Functional Release of Endogenous Opioids in the Locus Ceruleus during Stress Termination

Andre L. Curtis, Nicholas T. Bello, and Rita J. Valentino

The Children's Hospital of Philadelphia, 706 Abramson Pediatric Research Center, Philadelphia, Pennsylvania 19104

Endogenous opioids target noradrenergic locus ceruleus (LC) neurons and potently inhibit LC activity. Nonetheless, it has been difficult to demonstrate functional regulation of the LC-noradrenergic system by endogenous opioids because of the lack of effect of opiate antagonists. The present findings provide evidence that endogenous opioids regulate LC neuronal activity during the termination of a stressor. LC neuronal discharge was recorded from halothane-anesthetized rats before, during, and after hypotensive stress elicited by intravenous nitroprusside infusion. In naïve rats, mean arterial blood pressure was temporally correlated with LC activity such that hypotension was associated with increased LC discharge and a return to the normotensive state was associated with a decrease in LC discharge below pre-stress values. After microinfusion of an antagonist of the stress neuropeptide corticotropin-releasing factor (CRF) into the LC, the increase in LC discharge associated with hypotension was prevented, whereas LC inhibition associated with termination of the challenge occurred at an earlier time and was of a greater magnitude. In contrast, microinfusion of naloxone into the LC completely abolished LC inhibition associated with termination of the stressor. Naloxone microinfusion did not prevent LC inhibition associated with hypertension produced by intravenous vasopressin administration, suggesting that endogenous opioids may be selectively engaged during the termination of hypotensive stress. These results provide evidence for a functional release of endogenous opioids within the LC. This action of endogenous opioids may serve to counterbalance excitatory effects of CRF on the LC-norepinephrine system, thereby limiting its activation by stress.

Key words: corticotropin-releasing hormone; opiate; locus ceruleus; norepinephrine; hypotension; naloxone

---

Copyright © Society for Neuroscience  0270-6474//$05.00/0

This article has been cited by other articles:

				G.-P. Xu, E. Van Bockstaele, B. Reyes, T. Bethea, and R. J. Valentino Chronic Morphine Sensitizes the Brain Norepinephrine System to Corticotropin-Releasing Factor and Stress J. Neurosci., September 22, 2004; 24(38): 8193 - 8197. [Abstract] [Full Text] [PDF]

				J.-K. Zubieta, T. A. Ketter, J. A. Bueller, Y. Xu, M. R. Kilbourn, E. A. Young, and R. A. Koeppe Regulation of Human Affective Responses by Anterior Cingulate and Limbic {micro}-Opioid Neurotransmission Arch Gen Psychiatry, November 1, 2003; 60(11): 1145 - 1153. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help